OTC · Financial Statements

Dermisonics, Inc. (DMSI) Financial Statements

$0.00 OTC: DMSI Market Cap $1917

Dermisonics, Inc. most recently reported annual revenue of $0, net profit of $-5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric2003200420052006
Revenue$0$0$0$0
Operating Profit$0$0$-6.0M$-4.0M
Net Profit$0$-4.0M$-7.0M$-5.0M
EPS$0.00$-0.27$-0.17$-0.12
Op Margin————

Balance Sheet (USD)

Metric2003200420052006
Total Assets$0$19.0M$20.0M$20.0M
Total Liabilities$0$3.0M$4.0M$4.0M
Cash$0$0$0$0
Borrowings$0$2.0M$4.0M$3.0M

Cash Flow (USD)

Metric2003200420052006
Operating Cash Flow$0$0$-1.0M$-1.0M
Investing Cash Flow$0$-1.0M$0$0
Financing Cash Flow$0$0$0$-1.0M
Net Cash Flow$0$0$0$0
Free Cash Flow$0$-1.0M$-1.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.67
FCF Yield-68225.40%
Quick Ratio0.14
Interest Coverage-7.53
Return 1Y0.00%
Return 3Y-70.00%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
DMSI Overview DMSI Dividend Run Stock Screener